Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 virusesQIAOLI LI; ZHENHUAN ZHAO; YINGLIANG WU et al.Peptides (New York, NY. 1980). 2011, Vol 32, Num 7, pp 1518-1525, issn 0196-9781, 8 p.Article

Isolation and identification of an scFv antibody against nucleocapsid protein of SARS-CoVAIZHI ZHAO; WEIJUN QIN; YINGLU GUO et al.Microbes and infection. 2007, Vol 9, Num 8, pp 1026-1033, issn 1286-4579, 8 p.Article

Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4⁺ and CD8⁺ T cells promote cellular immune responsesJUN HUANG; YINGNAN CAO; JIALI DU et al.Vaccine. 2007, Vol 25, Num 39-40, pp 6981-6991, issn 0264-410X, 11 p.Article

SARS-CoV ORF1b-encoded nonstructural proteins 12-16: Replicative enzymes as antiviral targetsSUBISSI, Lorenzo; IMBERT, Isabelle; FERRON, François et al.Antiviral research. 2014, Vol 101, pp 122-130, issn 0166-3542, 9 p.Article

Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13YU, Mi-Sun; LEE, June; JIN MOO LEE et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 12, pp 4049-4054, issn 0960-894X, 6 p.Article

A complexity-based measure and its application to phylogenetic analysisXIAOQI ZHENG; CHUN LI; JUN WANG et al.Journal of mathematical chemistry. 2009, Vol 46, Num 4, pp 1149-1157, issn 0259-9791, 9 p.Article

Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndromeLEE, Nelson; CHAN, P. K. S; IP, Margaret et al.Journal of clinical virology. 2006, Vol 35, Num 2, pp 179-184, issn 1386-6532, 6 p.Article

Development of antiviral therapy for severe acute respiratory syndromeCINATL, Jindrich JR; MICHAELIS, Martin; HOEVER, Gerold et al.Antiviral research. 2005, Vol 66, Num 2-3, pp 81-97, issn 0166-3542, 17 p.Article

The SR-rich motif in SARS-CoV nucleocapsid protein is important for virus replicationTYLOR, Shaun; ANDONOV, Anton; CUTTS, Todd et al.Canadian journal of microbiology. 2009, Vol 55, Num 3, pp 254-260, issn 0008-4166, 7 p.Article

Thrombopoietin levels increased in patients with severe acute respiratory syndromeMO YANG; NG, Margaret H. L; CHI KONG LI et al.Thrombosis research. 2008, Vol 122, Num 4, pp 473-477, issn 0049-3848, 5 p.Article

Study on the resistance of severe acute respiratory syndrome-associated coronavirusWANG, Xin-Wei; LI, Jin-Song; SI, Bing-Yin et al.Journal of virological methods. 2005, Vol 126, Num 1-2, pp 171-177, issn 0166-0934, 7 p.Article

A universal microarray for detection of SARS coronavirusLONG, Wei-Hong; XIAO, Hua-Sheng; GU, Xiao-Mei et al.Journal of virological methods. 2004, Vol 121, Num 1, pp 57-63, issn 0166-0934, 7 p.Article

Accessory proteins of SARS-CoV and other coronavirusesDING XIANG LIU; TO SING FUNG; CHONG, Kelvin Kian-Long et al.Antiviral research. 2014, Vol 109, pp 97-109, issn 0166-3542, 13 p.Article

Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitorsLIU, I-Jung; KAO, Chuan-Liang; HSIEH, Szu-Chia et al.Antiviral research. 2009, Vol 81, Num 1, pp 82-87, issn 0166-3542, 6 p.Article

Chicken single-chain variable fragments against the SARS-CoV spike proteinLEE, Yu-Ching; LEU, Sy-Jye C; HU, Chaur-Jong et al.Journal of virological methods. 2007, Vol 146, Num 1-2, pp 104-111, issn 0166-0934, 8 p.Article

Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccineEDE QIN; HUIYING SHI; BINGYIN SI et al.Vaccine. 2006, Vol 24, Num 7, pp 1028-1034, issn 0264-410X, 7 p.Article

Inhibition of SARS-CoV replication by siRNAWU, Chang-Jer; HUANG, Hui-Wen; LIU, Chiu-Yi et al.Antiviral research. 2005, Vol 65, Num 1, pp 45-48, issn 0166-3542, 4 p.Article

Yeast expression and characterization of SARS-CoV N proteinSHISHU CAO; HAIHE WANG; LUHUR, Arthur et al.Journal of virological methods. 2005, Vol 130, Num 1-2, pp 83-88, issn 0166-0934, 6 p.Article

A single amino acid substitution in the Sl and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoVMITSUKI, Yu-Ya; OHNISHI, Kazuo; TSUNETSUGU-YOKOTA, Yasuko et al.Microbes and infection. 2008, Vol 10, Num 8, pp 908-915, issn 1286-4579, 8 p.Article

Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal modelLANYING DU; GUANGYU ZHAO; YUXIAN HE et al.Vaccine. 2007, Vol 25, Num 15, pp 2832-2838, issn 0264-410X, 7 p.Article

Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein : Revealing the critical antigenic determinants in inactivated SARS-CoV vaccineYUXIAN HE; JINGJING LI; LANYING DU et al.Vaccine. 2006, Vol 24, Num 26, pp 5498-5508, issn 0264-410X, 11 p.Article

Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th HospitalWANG, Xin-Wei; LI, Jin-Song; ZHU, Xiu-Mei et al.Journal of virological methods. 2005, Vol 128, Num 1-2, pp 156-161, issn 0166-0934, 6 p.Article

Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoVMANOPO, Ivanus; LIQUN LU; QIGAI HE et al.Journal of immunological methods. 2005, Vol 296, Num 1-2, pp 37-44, issn 0022-1759, 8 p.Article

Synthesis of Bioactive Natural Products as Protein InhibitorsKONNO, Hiroyuki.Bioscience, biotechnology, and biochemistry. 2012, Vol 76, Num 7, pp 1257-1261, issn 0916-8451, 5 p.Article

Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replicationAHN, Dae-Gyun; LEE, Wooseong; CHOI, Jin-Kyu et al.Antiviral research. 2011, Vol 91, Num 1, pp 1-10, issn 0166-3542, 10 p.Article